CME Group announced senior leadership appointments effective November 2, 2026, and March 2027. Jack Tobin will serve as Deputy Chief Financial Officer starting in November 2026 before becoming CFO in March 2027 upon Lynne Fitzpatrick's transition to CEO. Matthew Render succeeds Tobin as Chief Accounting Officer effective November 2, 2026. John Marchese is promoted to General Counsel, succeeding Jonathan Marcus who is stepping down. These changes are part of a previously announced succession plan and do not involve material financial terms or governance disputes. CME Group operates as the world's leading derivatives marketplace, enabling clients to trade futures, options, cash and OTC markets across major asset classes.

CME Group Inc. reported Q2 2026 financial results with revenue of $1.7 billion and net income of $1.0 billion, resulting in diluted earnings per share of $2.88. The company also reported record H1 2026 performance, record market data revenue of $238 million, and $95 billion in daily margin efficiencies. CME Group is a global derivatives marketplace operating in the financial services industry.

CME Group Inc. announced a leadership transition where Terrence A. Duffy will move to Executive Chairman on the later of March 1, 2027, or the 2026 10-K filing date, and Lynne C. Fitzpatrick will succeed him as CEO. Ms. Fitzpatrick's new employment agreement includes a $1.2 million annual base salary with a 200% annual bonus opportunity and 700% annual long-term incentive opportunity. CME Group Inc. operates in the financial services industry, providing exchange and clearing services for various financial instruments.

CME Group Inc. reconvened its 2026 Annual Meeting of Shareholders on June 9, 2026, following an initial adjournment due to lack of quorum for certain Class B stock classes. Proposals to eliminate the director election rights of Class B-1 and Class B-2 shareholders were defeated, and a proposal to amend the certificate of incorporation was contingent on those items and thus not filed. Class B-1 and Class B-2 directors were re-elected, while the Class B-3 director position remains a holdover due to a lack of quorum. CME Group Inc. operates in the financial services industry as a global exchange operator for derivatives and other financial instruments.

CME Group Inc. held its 2026 Annual Meeting of Shareholders on May 14, 2026, where shareholders elected Equity Directors and approved the appointment of Ernst & Young LLP as independent auditor. However, because Class B-1 through B-4 shares failed to reach a required quorum, proposals 4 through 8 have been adjourned to a follow-up meeting scheduled for June 9, 2026.